Viatris price target lowered to $13 from $15 at Jefferies

Jefferies analyst Glen Santangelo lowered the firm’s price target on Viatris (VTRS) to $13 from $15 and keeps a Buy rating on the shares after updating the firm’s for Q4 results and 2025 guidance. While fundamentals continue to improve, with 3% organic growth expected in FY25, the company’s negative headline EBITDA guidance has “overshadowed” improving operational performance, the analyst tells investors.